The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase II

被引：0
|
作者：
S. A. Paul Chubb
Kirsten E. Peters
David G. Bruce
Wendy A. Davis
Timothy M. E. Davis
机构：
[1] Fremantle Hospital,Medical School, Faculty of Health and Medical Sciences
[2] University of Western Australia,PathWest Laboratory Medicine Western Australia
[3] Fiona Stanley Hospital,undefined
来源：
Acta Diabetologica | 2022年 / 59卷
关键词：
Thyroid disease; Type 2 diabetes; Cardiovascular disease; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1615 / 1624
页数：9
相关论文
共 50 条
  • [1] The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase II
    Chubb, S. A. Paul
    Peters, Kirsten E.
    Bruce, David G.
    Davis, Wendy A.
    Davis, Timothy M. E.
    [J]. ACTA DIABETOLOGICA, 2022, 59 (12) : 1615 - 1624
  • [2] Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II
    Peters, Kirsten E.
    Chubb, Stephen A. Paul
    Bruce, David G.
    Davis, Wendy A.
    Davis, Timothy M. E.
    [J]. CLINICAL ENDOCRINOLOGY, 2020, 92 (04) : 373 - 382
  • [3] Clinical Impact of the Temporal Relationship between Depression and Type 2 Diabetes: The Fremantle Diabetes Study Phase II
    Bruce, David G.
    Davis, Wendy A.
    Cetrullo, Violetta
    Starkstein, Sergio E.
    Davis, Timothy M. E.
    [J]. PLOS ONE, 2013, 8 (12):
  • [4] Morbidity and mortality associated with hepatobiliary disease in type 2 diabetes: the Fremantle Diabetes Study
    Davis, T. M. E.
    Peters, K.
    Davis, W. A.
    [J]. DIABETOLOGIA, 2009, 52 : S525 - S525
  • [5] The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase I
    Davis, Timothy M. E.
    Davis, Wendy A.
    [J]. INTERNAL MEDICINE JOURNAL, 2022, 52 (07) : 1258 - 1262
  • [6] Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II
    Bruce, David G.
    Davis, Wendy A.
    Davis, Timothy M. E.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (12): : 2852 - 2859
  • [7] A contemporary Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study Phase II
    Davis, W. A.
    Hunter, M.
    Davis, T. M. E.
    [J]. DIABETOLOGIA, 2018, 61 : S575 - S576
  • [8] Lifetime depression and type 2 diabetes: the Fremantle diabetes study phase II
    Davis, W. A.
    Davis, T. M. E.
    Starkstein, S. E.
    Bruce, D. G.
    [J]. DIABETOLOGIA, 2012, 55 : S111 - S111
  • [9] COMORBID ANXIETY AND DEPRESSION AND THEIR IMPACT ON CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: THE FREMANTLE DIABETES STUDY PHASE II
    Bruce, David G.
    Davis, Wendy A.
    Dragovic, Milan
    Davis, Timothy M. E.
    Starkstein, Sergio E.
    [J]. DEPRESSION AND ANXIETY, 2016, 33 (10) : 960 - 966
  • [10] Associations between postural hypotension and neuropathy in type 2 diabetes: the Fremantle Diabetes study phase II
    Davis, T. M. E.
    Knapp, A.
    Davis, W. A.
    [J]. DIABETOLOGIA, 2013, 56 : S492 - S493
12345